Philogen logo.png
Philogen Provides Corporate Update
12. November 2021 02:00 ET | Philogen
Philogen Provides Corporate Update Nidlegy™ and Fibromun are on track with planned timelines in pivotal clinical trialsFibromun shows potent activity in last-line glioblastoma in combination with...
Philogen logo.png
Philogen Provides Corporate Update
29. September 2021 04:58 ET | Philogen
Philogen Provides Corporate Update Nidlegy™ and Fibromun on track with planned timelines in pivotal clinical trialsUse of Nidlegy™ in non-melanoma skin cancer expanded in Phase II clinical...